Journal article icon

Journal article

The deferred promise of radical cure: pharmaceutical conjugations of malaria in the global health era

Abstract:

This paper explores the changing political economy of malaria drug discovery by tracing the career over the last four decades of a single molecule, tafenoquine. First identified as a promising antimalarial by the US Army in the 1970s, tafenoquine has recently been approved by the Food and Drug Administration for the radical cure of vivax malaria – the first product to receive marketing authorization for this indication in more than 65 years. The new drug is the result of a collaboration betwe...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1080/03085147.2018.1528075

Authors


More by this author
Institution:
University of Oxford
Division:
SSD
Department:
SAME
Sub department:
Social & Cultural Anthropology
Oxford college:
Kellogg College
Role:
Author
Publisher:
Taylor and Francis Publisher's website
Journal:
Economy and Society Journal website
Volume:
47
Issue:
4
Pages:
547-571
Publication date:
2018-11-27
Acceptance date:
2018-09-12
DOI:
EISSN:
1469-5766
ISSN:
0308-5147
Source identifiers:
918931
Language:
English
Keywords:
Pubs id:
pubs:918931
UUID:
uuid:0b45bb5f-be7b-41bf-8146-9eed1ebd160a
Local pid:
pubs:918931
Deposit date:
2018-09-12

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP